Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Nucl Med. 2010 Sep 16;51(10):1600–1607. doi: 10.2967/jnumed.110.077149

TABLE 3.

131I-Lipiodol Patient: Cumulated Activity, Organ Mass, Dose Calculated by VSV and 3D-RD, and Relative Differences for Corresponding ROIs

ROI Cumulated activity (MBq·s) Mass (g) Dose for VSV (Gy) Dose for 3D-RD 108 histories (Gy) Percentage relative difference with VSV Voxel-to-voxel ratio mode
Liver 7.89E+08 1675 14.3 14.2 0.94 0.994 (0.017)
Tumor 4.44E+07 15.3 86.7 86.1 0.67 0.991 (0.008)

Data in parentheses are SD.